Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Currie

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
Diabetic Medicine : a Journal of the British Diabetic Association|June 19, 1998
The demand and financial cost of hospital care for diabetes mellitus and its related complicationsC J Currie, J R Peters
Drug Safety|February 15, 2000
Use of routine healthcare data in safe and cost-effective drug useC J Currie, T M MacDonald
Diabetes, Obesity & Metabolism|February 19, 2014
Mortality risk with sulphonylureas compared to metforminS E Holden, C J Currie
Diabetes, Obesity & Metabolism|July 22, 2014
Optimizing clinical outcomes resulting from glucose-lowering therapies in type 2 diabetes: increased confidence about the DPP-4 inhibitors and continued concerns regarding sulphonylureas and exogenous insulinC J Currie, S E Holden
Diabetic Medicine : a Journal of the British Diabetic Association|February 13, 2001
The cost of diabetes: time for a different approach?S Dixon, C J Currie, J R Peters
Rheumatology (Oxford, England)|December 6, 2008
An evaluation of the association between C-reactive protein, the change in C-reactive protein over one year, and all-cause mortality in chronic immune-mediated inflammatory disease managed in UK general practiceC D Poole, P Conway, C J Currie
Diabetes, Obesity & Metabolism|December 22, 2007
Re: Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the USC J Currie, M Evans, C D Poole
BMJ (Clinical Research Ed.)|March 1, 1997
Ratio of inhaled corticosteroid to bronchodilator as indicator of quality of asthma prescribing. More adequate information systems are neededC J Currie, M Evans, C L Morgan
Heart (British Cardiac Society)|September 1, 2007
Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortalityC J Currie, C D Poole, P Conway
Diabetic Medicine : a Journal of the British Diabetic Association|July 20, 2010
Dispensing patterns and financial costs of glucose-lowering therapies in the UK from 2000 to 2008C J Currie, J R Peters, M Evans
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Diabetic Medicine : a Journal of the British Diabetic Association|June 19, 1998
The demand and financial cost of hospital care for diabetes mellitus and its related complicationsC J Currie, J R Peters
Drug Safety|February 15, 2000
Use of routine healthcare data in safe and cost-effective drug useC J Currie, T M MacDonald
Diabetes, Obesity & Metabolism|February 19, 2014
Mortality risk with sulphonylureas compared to metforminS E Holden, C J Currie
Diabetes, Obesity & Metabolism|July 22, 2014
Optimizing clinical outcomes resulting from glucose-lowering therapies in type 2 diabetes: increased confidence about the DPP-4 inhibitors and continued concerns regarding sulphonylureas and exogenous insulinC J Currie, S E Holden
Diabetic Medicine : a Journal of the British Diabetic Association|February 13, 2001
The cost of diabetes: time for a different approach?S Dixon, C J Currie, J R Peters
Rheumatology (Oxford, England)|December 6, 2008
An evaluation of the association between C-reactive protein, the change in C-reactive protein over one year, and all-cause mortality in chronic immune-mediated inflammatory disease managed in UK general practiceC D Poole, P Conway, C J Currie
Diabetes, Obesity & Metabolism|December 22, 2007
Re: Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the USC J Currie, M Evans, C D Poole
BMJ (Clinical Research Ed.)|March 1, 1997
Ratio of inhaled corticosteroid to bronchodilator as indicator of quality of asthma prescribing. More adequate information systems are neededC J Currie, M Evans, C L Morgan
Heart (British Cardiac Society)|September 1, 2007
Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortalityC J Currie, C D Poole, P Conway
Diabetic Medicine : a Journal of the British Diabetic Association|July 20, 2010
Dispensing patterns and financial costs of glucose-lowering therapies in the UK from 2000 to 2008C J Currie, J R Peters, M Evans
Pageof 7